Company news

Aurobindo Pharma Ltd news in 2024

Aurobindo Pharma Ltd's news releases, calls and decks from 2024, newest first.

View company

Press Release Dec 21 2024

December 21, 2024

Press Release Dec 13 2024

December 13, 2024

Press Release Dec 05 2024

December 5, 2024

Annual CSR Report 2023-24

November 27, 2024

Press Release Nov 12 2024

November 12, 2024

Q2 UFR 2024 25 Corrigendum in Consolidated UFR

November 11, 2024

Press Release Nov 09 2024

November 9, 2024

Q2FY25

November 4, 2024

Press Release Oct 29 2024

October 29, 2024

Press Release Oct 01 2024

October 1, 2024

Press Release Aug 10 2024

August 10, 2024

Press Release Aug 06 2024

August 6, 2024

Annual Report 2023-24

August 5, 2024

Q1FY25

August 5, 2024

Aurobindo Pharma receives USFDA Approval for Mometasone Furoate Monohydrate Nasal Spray

May 31, 2024

Press Release May 25 2024

May 25, 2024

Q4FY24

May 17, 2024

Press Release Mar 19 2024

March 19, 2024

Press Release Mar 15 2024

March 15, 2024

Press Release Mar 01 2024

March 1, 2024

Press Release Feb 12 2024

February 12, 2024

Press Release Feb 10 2024

February 10, 2024

Decks in 2024